{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:36:58Z","timestamp":1720676218571},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.lpm.2006.07.012","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T05:54:08Z","timestamp":1201326848000},"page":"604-611","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Utilisation hors recommandations des\u00a0m\u00e9dicaments innovants et\u00a0co\u00fbteux en\u00a0p\u00e9diatrie"],"prefix":"10.1016","volume":"36","author":[{"given":"Tiphaine","family":"Legrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Mille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bourdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Boulan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karima","family":"Yakouben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Brion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2006.07.012_bib1","unstructured":"Minist\u00e8re de la Sant\u00e9, de la Famille et des Personnes handicap\u00e9es http:\/\/www.sante.gouv.fr\/htm\/dossiers\/t2a\/accueil.htm (consult\u00e9 le 6 d\u00e9cembre 2005)."},{"key":"10.1016\/j.lpm.2006.07.012_bib2","unstructured":"D\u00e9cret relatif au contrat de Bon Usage des M\u00e9dicaments et produits et prestations mentionn\u00e9 \u00e0 l'article L.162-22-7 du code de la s\u00e9curit\u00e9 sociale."},{"key":"10.1016\/j.lpm.2006.07.012_bib3","first-page":"1195","article-title":"M\u00e9dicament de l\u2019enfant: il est temps d'agir","volume":"12","author":"Saint-Raymond","year":"2005","journal-title":"Arch\u00a0Ped."},{"key":"10.1016\/j.lpm.2006.07.012_bib4","series-title":"Informatique et m\u00e9dicaments","first-page":"170","article-title":"La\u00a0prescription pharmaceutique informatis\u00e9e dans PCS: Principe et Exp\u00e9rience","author":"Rudnichi","year":"1989"},{"key":"10.1016\/j.lpm.2006.07.012_bib5","unstructured":"Recommandations de bon usage des immunoglobulines intraveineuses polyvalentes dans les indications reconnues par le comit\u00e9 d\u2019experts IgIV de l'AP-HP \u2013 CEDIT- Novembre 2003."},{"key":"10.1016\/j.lpm.2006.07.012_bib6","first-page":"1323","article-title":"Oral immunoglobulins for gastroenteritis","volume":"30","author":"Dattani","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.lpm.2006.07.012_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1542\/peds.93.1.12","article-title":"Oral immunoglobulins for treatment of acute rotaviral gastroenteritis","volume":"93","author":"Guarino","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.lpm.2006.07.012_bib8","unstructured":"Fiches de bon usage des m\u00e9dicaments mentionn\u00e9s \u00e0 l'article L.162-22-7 du code de la S\u00e9curit\u00e9 sociale \u00e9dit\u00e9es par la Commission des Pharmaciens de CHU: http:\/\/www.adiph.org\/bonusage\/index.html (consult\u00e9 le 18 mai 2006)."},{"key":"10.1016\/j.lpm.2006.07.012_bib9","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lpm.2006.07.012_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.inf.0000078164.80233.14","article-title":"Retrospective study of the safety of caspofungin in immunocompromised pediatric patients","volume":"8","author":"Franklin","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lpm.2006.07.012_bib11","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archneur.62.11.1673","article-title":"Acute disseminated encephalomyelitis: an update","volume":"62","author":"Menge","year":"2005","journal-title":"Arch Neurol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498206001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498206001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:18:52Z","timestamp":1684207132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498206001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0755498206001874"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2006.07.012","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}